Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization

BACKGROUND AND OBJECTIVE: Many people living with HIV (PLWH) on stable tenofovir disoproxil fumarate (TDF)-containing regimens have switched to tenofovir alafenamide (TAF), despite the potential lipid-lowering effect of TDF. We aimed to assess the impact of switching from TDF to TAF on lipids in rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunet, Laurence, Mallon, Patrick, Fusco, Jennifer S., Wohlfeiler, Michael B., Prajapati, Girish, Beyer, Andrew, Fusco, Gregory P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556204/
https://www.ncbi.nlm.nih.gov/pubmed/34546533
http://dx.doi.org/10.1007/s40261-021-01081-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556204/
https://www.ncbi.nlm.nih.gov/pubmed/34546533
http://dx.doi.org/10.1007/s40261-021-01081-y

Ejemplares similares